NOXAFIL

This brand name is authorized in Austria, Brazil, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug NOXAFIL contains one active pharmaceutical ingredient (API):

1 Posaconazole UNII 6TK1G07BHZ - POSACONAZOLE

Posaconazole inhibits the enzyme lanosterol 14α-demethylase (CYP51), which catalyses an essential step in ergosterol biosynthesis. Read about Posaconazole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NOXAFIL Oral suspension	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J02AC04	Posaconazole	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AC Triazole and tetrazole derivatives
Discover more medicines within J02AC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 527315120017517
Country: EE	Ravimiamet	Identifier(s): 1218866, 1646175, 1646186, 1666065, 1873054
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 05320001, 105320002, 105320004
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 027795, 151012, 433666, 476142
Country: FR	Base de données publique des médicaments	Identifier(s): 62076503, 65644772, 69380042
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 100537, 245566, 245567, 280018
Country: HK	Department of Health Drug Office	Identifier(s): 56439
Country: IE	Health Products Regulatory Authority	Identifier(s): 88380, 88420
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6101, 8005
Country: IT	Agenzia del Farmaco	Identifier(s): 037059019, 037059021
Country: JP	医薬品医療機器総合機構	Identifier(s): 6179002H1029, 6179403A1028
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1029696, 1074065, 1074066, 1075485
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 117498, 120642, 79553
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11912, 16186
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100143564, 100317604, 100367000
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64692001, W64693001, W64693002, W64694001
Country: SG	Health Sciences Authority	Identifier(s): 13654P, 15045P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699636041284, 8699636041291, 8699636280799, 8699636791271
Country: US	FDA, National Drug Code	Identifier(s): 0085-1328, 0085-4324, 0085-4331
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/20.3/0719